Professor, Medicine, UCLA School of Medicine
Gastroenterology
Dr. Lin F. Chang, MD
|
|
Give Review
Chang works in the field of Gastroenterology. She researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care She received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)", "Fellow (FACG)" and "Super Doctor". Lin F. Chang is a published doctor and has 39 publications published. The lastest was: 'Skin Examination Practices Among Melanoma Survivors and Their Children.' Lin F. Chang accepts all Medicare patients.
Publications
- Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel Syndrome.
- A Diet-Sensitive BAF60a-Mediated Pathway Links Hepatic Bile Acid Metabolism to Cholesterol Absorption and Atherosclerosis.
- The liver clock controls cholesterol homeostasis through Trib1-mediated regulation of PCSK9/LDLR.
- Diminished expression of CRHR2 in human colon Cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.
- FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
- A cross-cultural investigation of attachment style, catastrophizing, negative Pain beliefs, and symptom severity in irritable bowel syndrome.
- Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles.
- Sun protection practices and sun exposure among children with a parental history of melanoma.
- Interactions of early adversity with stress-related gene polymorphisms impact Regional brain structure in females.
- Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes.
- Computer-Generated Vs. Physician-Documented History of Present Illness (HPI): Results of a Blinded Comparison.
- The impact of Abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two...
- Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales.
- American Gastroenterological Association Technical Review on the Pharmacological Management of Irritable Bowel Syndrome.
- GERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients.
- Safety and tolerability of rifaximin for the treatment of irritable bowel Syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-control...
- Construct validity of the Patient Reported Outcomes Measurement Information System (PROMIS®) gastrointestinal symptom scales in Systemic sclerosis.
- Characterization of symptoms in irritable bowel Syndrome with mixed bowel habit pattern.
- Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database.
- An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.
- Identification of a Functional TPH1 Polymorphism Associated With Irritable Bowel Syndrome Bowel Habit Subtypes.
- A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.
- Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of Disease.
- A Mindful Way Through Ibs: Reducing Abdominal Pain And Improving Quality Of Life.
- Brain-gut interactions: implications for newer therapy.
- Approaches to the modulation of Abdominal pain.
- Impact of advertisement and clinic populations in symptoms and perception of irritable bowel Syndrome.
- Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel Syndrome patients.
- Differences in somatic perception in female patients with irritable bowel Syndrome with and without fibromyalgia.
- Gender differences in Regional brain response to visceral pressure in IBS patients.
- Perceptual responses in patients with inflammatory and functional bowel Disease.
- V. Stress and irritable bowel Syndrome.
- Basic pathophysiologic mechanisms in irritable bowel Syndrome.
- Functional GI Disorders: from animal models to drug development.
- Neural and psychological predictors of treatment response in irritable bowel Syndrome patients with a 5-HT3 receptor antagonist: a pilot study.
- Gender differences in irritable bowel Syndrome.
- Evolving pathophysiological model of functional gastroIntestinal disorders: implications for treatment.
- Skin Examination Practices Among Melanoma Survivors and Their Children.
Schools
University of California At Los Angeles
La Co Harbor UCLA Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Colorectal Cancer
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Fellow (FACG)
- Super Doctor
Education
-
Harbor - UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Payman Khorrami, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey R. Lewis, MD |
|
|
Dr. Wendy W. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farshid S. Rahbar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Zelman G. Weingarten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon W. Beaven, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Yeh, MD |
|
|
Dr. Gary Gitnick, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hannah H. Do, MD |
|
|
Dr. David M. Padua, MD |
|
|
Dr. Laura A. McEnerney, MD |
|
|
Gati A. Goel |